A型肝炎ワクチンの失敗は,

Same author

Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.

NPJ vaccines·2026

Same author

A science-based product regulation: the time has come to reduce toxic emissions to reduce harm.

Frontiers in public health·2025

Same author

Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like Particles.

Analytical chemistry·2025

Same author

Adenovirus vectors can infect mouse megakaryocytes - implications for vaccine-induced thrombosis/thrombocytopenia.

Research and practice in thrombosis and haemostasis·2025

Same author

A Robust Human Liver Organoid Model of Hepatitis B Virus Infection.

Methods in molecular biology (Clifton, N.J.)·2025

Same author

Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale.

Biotechnology and bioengineering·2025

Same journal

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Lancet (London, England)·2026

Same journal

Documenting hospice care.

Lancet (London, England)·2026

Same journal

After the wood chipper.

Lancet (London, England)·2026

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

関連する実験動画

A型肝炎ワクチンの失敗は,

関連する概念動画

Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.

A science-based product regulation: the time has come to reduce toxic emissions to reduce harm.

Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like Particles.

Adenovirus vectors can infect mouse megakaryocytes - implications for vaccine-induced thrombosis/thrombocytopenia.

A Robust Human Liver Organoid Model of Hepatitis B Virus Infection.

Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

関連する実験動画

A型肝炎ワクチンの失敗は,

関連する概念動画

関連記事

Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59.

A science-based product regulation: the time has come to reduce toxic emissions to reduce harm.

Spectroscopic Characterization and Differentiation of SARS-CoV-2 Virus-like Particles.

Adenovirus vectors can infect mouse megakaryocytes - implications for vaccine-induced thrombosis/thrombocytopenia.

A Robust Human Liver Organoid Model of Hepatitis B Virus Infection.

Development of Methods to Produce SARS CoV-2 Virus-Like Particles at Scale.

Inherited retinal degenerations: clinical phenotypes and emerging therapies.

Documenting hospice care.

After the wood chipper.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.